1.
Ferrario L, Menzaghi B, Rizzardini G, Roccia A, Garagiola E, Bellavia D, Schettini F, Foglia E. Optimization in the HIV treatment: economic and organizational impact analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide. Grhta [Internet]. 2025 Feb. 26 [cited 2025 Mar. 12];12(1):49-60. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3292